Opportunity Alert – NIH SBIR Programs and Deadlines

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, also known as America’s Seed Fund, are one of the largest sources of early-stage capital for technology commercialization in the United States. These programs allow US-owned and operated small businesses to engage in federal research and development that has a strong potential for commercialization.

Targeted SBIR/STTR Funding Announcements

Receipt dates for the following Program Announcements (PAs) and Request for Applications (RFAs) may vary. See the NIH Guide for Grants and Contracts for all NIH RFA and PA announcements. 

SBIR and STTR Omnibus Solicitations (Parent Announcements)

  • SBIR Omnibus/Parent Clinical Trial Not Allowed Funding Opportunity Announcement (PA-18-574)
  • STTR Omnibus/Parent Clinical Trial Not Allowed Funding Opportunity Announcement (PA-18-575)
  • SBIR Omnibus/Parent Clinical Trial Required Funding Opportunity Announcement (PA-18-573)
  • STTR Omnibus/Parent Clinical Trial Required Funding Opportunity Announcement (PA-18-576)

Deadlines: April 5, 2018; September 5, 2018; January 7, 2019; April 5, 2019

To view all SBIR and STTR Funding Opportunities  (84 Records – Sorted by Release Date) click here.


Attention device developers:

You can access specialized business frameworks and essential tools to successfully translate your technology from the lab to market by applying for the Concept to Clinic: Commercializing Innovation (C3i) funding supplement  PA-18-702.

Due Dates: June 1, 2018 and August 1, 2018, by 5:00PM ET

C3i’s curriculum and customized mentoring will guide you as you assess the commercial viability and potential business opportunity for your innovation, and will help define your value proposition in addressing an unmet market need.

More information is available in the full Funding Opportunity Announcement PA-18-702 and by contacting

Mike Pieck, PhD 
National Heart, Lung, and Blood Institute (NHLBI) 
Telephone: 301-827-7986 
Email: mike.pieck@nih.gov


Oct 30 – Nov 1 Save the Date:

Meet with NHLBI at the HHS SBIR/STTR Conference

20th Annual HHS SBIR/STTR Conference

October 30 – November 1, 2018

Dallas, Texas

Registration Not Yet Open

This conference is relevant to a diverse audience, including biomedical entrepreneurs; principal investigators; grants and contracts administrators; and industry partners and investors.

Top 3 Reasons to Attend:

  1.  Meet one-on-one with HHS SBIR/STTR program managers

Over 100 federal staff, including representatives from the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), Small Business Administration (SBA), Administration for Community Living (ACL), and HHS Office of the Inspector General (OIG) will be holding one-on-one meetings and giving presentations. You will have the chance to get one-on-one feedback about your technology proposal!

  1.  Hear from successful HHS SBIR/STTR awardees 

Gain first-hand knowledge from experienced and successful applicants, potential funding partners and companies during interactive workshops and sessions. These sessions include a diverse group of successful awardees, including women-owned small businesses and socially and economically disadvantaged small businesses.

  1.  Learn how to develop a competitive application

Many sessions focus on how to develop and submit your SBIR/STTR application. Topics include:

  • How to submit your SBIR/STTR grant proposal electronically via ASSIST
  • FDA regulatory requirements for drugs and devices
  • Important considerations to protect your intellectual property
  • Top 10 Dos and Don’ts for SBIR/STTR proposal development
  • Understanding indirect costs and financial accounting systems
  • What you need to know about human subjects and animal research

The differences between SBIR grants and contracts

Posted in AZBio News.